Crinetics Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-3.698; its P/E ratio is -11.95; Crinetics Pharmaceuticals is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $-0.81. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 346.00K	$ 988.00K	$ 2.68M	$ -4.03M	$ 458.00K
Gross Profit	$ 346.00K	$ 988.00K	$ 2.68M	$ -3.43M	-
EBIT	$ -57.46M	$ -50.98M	$ -45.99M	$ -46.96M	$ -43.45M
EBITDA	$ -58.43M	$ -51.61M	$ -46.24M	$ -47.03M	$ -43.21M
Net Income Common Stockholders	$ -57.46M	$ -50.98M	$ -45.99M	$ -45.05M	$ -41.92M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 554.65M	$ 264.53M	$ 296.12M	$ 334.43M	$ 368.36M
Total Assets	$ 641.54M	$ 293.25M	$ 314.01M	$ 352.18M	$ 384.88M
Total Debt	$ 52.17M	$ 2.56M	$ 2.82M	$ 2.02M	$ 3.32M
Net Debt	$ -502.48M	$ -261.96M	$ -293.30M	$ -332.40M	$ -365.04M
Total Liabilities	$ 93.79M	$ 39.14M	$ 33.68M	$ 35.85M	$ 33.51M
Stockholders Equity	$ 547.75M	$ 254.16M	$ 280.33M	$ 316.33M	$ 351.37M
Cash Flow	-
Free Cash Flow	$ -44.84M	$ -45.97M	$ -40.73M	$ -35.48M	$ -39.16M
Operating Cash Flow	$ -41.34M	$ -45.73M	$ -40.72M	$ -35.21M	$ -38.48M
Investing Cash Flow	$ -193.30M	$ 31.44M	$ 48.76M	$ 36.85M	$ 6.82M
Financing Cash Flow	$ 337.88M	$ 12.66M	$ 484.00K	$ 115.00K	$ 1.08M

Currency in USD

Crinetics Pharmaceuticals Earnings and Revenue History

Income Statement >

Crinetics Pharmaceuticals Debt to Assets

Balance Sheet >

Crinetics Pharmaceuticals Cash Flow

Cash Flow >

Crinetics Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing